Based on the median expression index of 4.0, determined by the IHC score for CCL7 protein expression levels in a cohort of 50 patients with hepatocellular carcinoma (HCC), the patients were categorized into two groups: CCL7‐strongly positive and CCL7‐weakly positive. This evidence concerns the gene CCL7 and hepatocellular carcinoma.